Background: Healthcare workers are at the forefront of the ongoing COVID-19 pandemic and are at high risk for both the contraction and subsequent spread of virus. Understanding the role of anosmia as an early symptom of infection may improve monitoring and management of SARS-CoV2 infection.
Methodology: We conducted a systematic review of the literature of SARS-CoV2 infection/COVID-19 and anosmia to help inform management of anosmia in healthcare works. We report a case series of healthcare workers, who presented with a loss of sense of smell secondary to COVID-19 infection to demonstrate management principles. RT-PCR was used to confirm COVID-19 positivity and psychophysical testing of olfaction was performed using the British version of the University of Pennsylvania Smell Identification Test, UPSIT.
Results: The systematic literature search returned 31 articles eligible for inclusion in the study and informed our recommendations for clinical assessment and management. All three healthcare professionals who presented with loss of sense of smell subsequently tested positive for SARS-CoV-2. Psychophysical testing of olfaction using the UPSIT confirmed mild and moderate microsmia in two, respectively, and normosmia at day 17 in one.
Conclusions: Olfactory (± gustatory) dysfunction is indicative of COVID-19 infection and thus has important implications in the context of healthcare workers, or key workers in general, who work in close contact with others if not recognised as suffering from COVID. This leads to a potentially higher likelihood of spreading the virus. In conjunction with our literature review these findings have helped with creating recommendations on the assessment and management of olfactory dysfunction during the ongoing COVID-19 pandemic, both for healthcare workers and patients.
Smell dysfunction: a biomarker for COVID-19.Int Forum Allergy Rhinol. 2020 Apr 17. doi: 10.1002/alr.22587. Online ahead of print. Int Forum Allergy Rhinol. 2020. PMID: 32301284
The role of self-reported smell and taste disorders in suspected COVID‑19.Eur Arch Otorhinolaryngol. 2020 May 23:1-6. doi: 10.1007/s00405-020-06069-6. Online ahead of print. Eur Arch Otorhinolaryngol. 2020. PMID: 32447496 Free PMC article.
Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.Otolaryngol Head Neck Surg. 2020 May 19:194599820929185. doi: 10.1177/0194599820929185. Online ahead of print. Otolaryngol Head Neck Surg. 2020. PMID: 32423357 Free PMC article.
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.Compr Psychiatry. 2020 May 11;100:152184. doi: 10.1016/j.comppsych.2020.152184. Online ahead of print. Compr Psychiatry. 2020. PMID: 32422426 Free PMC article. Review.
Anaesthesia and COVID-19: infection control.Br J Anaesth. 2020 Apr 8:S0007-0912(20)30200-2. doi: 10.1016/j.bja.2020.03.025. Online ahead of print. Br J Anaesth. 2020. PMID: 32307115 Free PMC article. Review.